316 related articles for article (PubMed ID: 2463720)
1. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of chronic ventricular arrhythmias with the new class Ic anti-arrhythmia agent diprafenon--results of long-term therapy].
Heuer H; Gülker H; Hasfeld M; Frenking B; Behrenbeck T
Z Kardiol; 1987 Jul; 76(7):415-20. PubMed ID: 3673163
[TBL] [Abstract][Full Text] [Related]
3. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
Garimoldi M; Sghirinzetti M; Pirastu A; Cappiello E; Sala R; Terranova P
G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383
[TBL] [Abstract][Full Text] [Related]
4. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole].
Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Huguet R; Wajman A
Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1495-505. PubMed ID: 2432845
[TBL] [Abstract][Full Text] [Related]
6. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the antiarrhythmic profile of the new class I agent diprafenone.
Gülker H; Thale J; Olbing B; Heuer H; Frenking B; Bender F
Arzneimittelforschung; 1985; 35(9):1387-93. PubMed ID: 4084340
[TBL] [Abstract][Full Text] [Related]
8. [Significance of cardiac arrhythmias in the aged and their treatment with propafenone controlled by plasma level].
Lachnit KS; Rieder L
Z Gerontol; 1985; 18(6):343-52. PubMed ID: 2420079
[TBL] [Abstract][Full Text] [Related]
9. [Comparative studies of tocainide and propafenone in the treatment of ventricular arrhythmias].
Gebhardt A; Schmuderer R; Hilpert P
Arzneimittelforschung; 1984; 34(3):303-6. PubMed ID: 6428425
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of ventricular arrhythmias with propafenone].
Petri H; Kafka W; Rudolph W
Herz; 1985 Feb; 10(1):44-52. PubMed ID: 2579879
[TBL] [Abstract][Full Text] [Related]
11. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
[TBL] [Abstract][Full Text] [Related]
12. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
[TBL] [Abstract][Full Text] [Related]
13. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
Klempt HW; Nayebagha A; Fabry E
Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
[TBL] [Abstract][Full Text] [Related]
14. [Electrophysiologic and hemodynamic effects of the new anti-arrhythmia agent diprafenone].
Gülker H; Heuer H; Thale J; Behrenbeck T
Z Kardiol; 1987 Jul; 76(7):411-4. PubMed ID: 3673162
[TBL] [Abstract][Full Text] [Related]
15. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
Manz M; Beermann J; Gerckens U; Lüderitz B
Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
[TBL] [Abstract][Full Text] [Related]
16. [Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine].
Zehender M; Geibel A; Hust M; Hohnloser S; Meinertz T; Just H
Z Kardiol; 1987 Aug; 76(8):501-6. PubMed ID: 2445118
[TBL] [Abstract][Full Text] [Related]
17. Antiarrhythmic effectiveness of propafenone compared to lorajmine in ventricular arrhythmias. Controlled clinical trial.
Sanna G; Meoli P; Bianchini C; Rovelli F
G Ital Cardiol; 1983; 13(3):145-51. PubMed ID: 6350090
[TBL] [Abstract][Full Text] [Related]
18. [Propafenone in ventricular extrasystole in elderly patients. Tolerance and efficacy].
Camous JP; Benoit P; Vrancea F; Gibelin P; Schenowitz A; Baudouy M; Varenne A; Morand P
Ann Cardiol Angeiol (Paris); 1987 Apr; 36(4):179-82. PubMed ID: 2438971
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre study.
Geibel A; Meinertz T; Zehender M; Vitak J; Hohnloser S; Kunz-Fritze A; Just H
Eur Heart J; 1989 Sep; 10 Suppl E():81-7. PubMed ID: 2680506
[TBL] [Abstract][Full Text] [Related]
20. [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms].
Mastropasqua F; Totaro P; Massari F; Pitzalis MV; Rizzon P
Cardiologia; 1998 Jun; 43(6):617-23. PubMed ID: 9675961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
